About 301,000 results
Open links in new tab
  1. Beyond Triple Therapy: Next Steps for Resistant Hypertension

    Jan 2, 2026 · Thelma’s blood pressure remains high despite triple therapy. Dr Vega applies the 2025 ACC/AHA guidelines to determine the best next step for his patient.

  2. Safety Plan: A Physical Resource for a Mental Health Crisis

    2 days ago · Dr Kaitlin Sanzone discusses tips for creating a safety plan for mental health crises.

  3. Highlights in ER+ Breast Cancer From SABCS 2025 - Medscape

    3 days ago · Highlights in ER-positive breast cancer from SABCS 2025 include key metastatic and early-stage trial results from AMBRE, DETECT-V, ASCENT-07, and lidERA, as reported …

  4. Chronic Myeloid Leukemia Highlights From ASH 2025 - Medscape

    Dec 30, 2025 · Chronic myeloid leukemia highlights from ASH 2025 include data on nilotinib vs imatinib, asciminib in second line, somatic mutations and imatinib failure, and dasatinib with a …

  5. The Art of a Consult - Medscape

    You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our …

  6. FDA Plans to Remove Black Box Warning From HRT Products

    The US Food and Drug Administration intends to remove most black box warnings from products containing estrogen and progestogen. The decision, announced Monday, is part of a …

  7. Baking Soda Skin Hacks: The Sting Isn’t Worth the Rub

    Over the past several years, skinfluencers have gathered on TikTok to tout the benefits of baking soda-based mixtures, scrubs, and overnight masks.

  8. How to Address Potential Red Flags on Applications - Medscape

    Dr Nayiri Guedikian discusses how to address potential red flags on applications.

  9. Clinical Judgment: Transitioning to Residency - Medscape

    Dr Kaitlin Sanzone discusses the transition from medical school to residency.

  10. Advances in PNH From ASH 2025 - Medscape

    Dec 31, 2025 · Artificial intelligence to speed diagnosis, switching complement therapies, ravulizumab during pregnancy, and iptacopan outcomes are some of the PNH advances from …